checkAd

     104  0 Kommentare Cutera, Inc. Announces First Quarter 2021 Financial Results

    Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the first quarter ended March 31, 2021.

    First Quarter 2021 Financial and Operational Highlights

    • Revenue was $49.7 million, an increase of 54.1% from the prior-year period, driven by strong performance across the business, with particular strength in capital equipment and skincare sales.
      • Capital Equipment revenue of $28.3 million increased 35.1% over the prior-year period.
      • Recurring revenue, defined by the combination of Skincare, Consumable Products, and Service, was $21.3 million, an increase of 89.2% over the prior-year period:
        • Skincare revenue of $12.3 million increased 324.4% over the prior-year period;
        • Consumable Product revenue of $2.9 million grew 15.5% over prior-year period, reflecting the continued recovery of energy-based treatment volumes; and
        • Service revenue of $6.1 million increased 4.6% over the prior-year period.
    • Gross Margin was 55.8%, compared to 44.5% in the prior-year period, due to ongoing improvements in manufacturing efficiencies, offset by mix shift associated with growth of skincare during the quarter;
    • Operating Expenses were $26.5 million in the quarter, flat to prior-year period;
    • Adjusted EBITDA was $4.6 million in the period as compared to $(8.3) million, a $12.9 million improvement over prior-year period; and
    • Net loss was ($0.4) million, or ($0.02) per fully diluted share, compared to a net loss of ($12.4) million, or ($0.86) per fully diluted share, in the prior-year period;
    • Announced pricing of offering of $138.3 million of convertible senior notes.

    “I am pleased with our first-quarter results, which reflect the continued progress we have made since the onset of the COVID-19 pandemic,” commented Dave Mowry, Chief Executive Officer of Cutera, Inc. “In the first-quarter, we achieved broad strength across our business, driven by consistent execution from our commercial teams, strength in the skincare business, and a slow but steady improvement in our end markets. Building upon the tremendous work from our team, in 2021 we plan to continue to improve gross margins by reducing manufacturing costs; increase sales and sales productivity with our focus on people and process; and deliver innovative products through our increased R&D investments. As we execute these vital few initiatives, our objective is to deliver strong performance despite the remaining pandemic uncertainties that will likely be headwinds for many of us in this market.”

    2021 Outlook

    Company management remains cautious with the lingering uncertainty related to COVID-19. Global Energy-based Aesthetics end markets continued to improve over the course of the first quarter, but the pace and extent of customer recovery varied by geography. With several geographies still under activity restrictions, management is not issuing full-year guidance at this time.

    Conference Call

    The Company’s management will host a conference call to discuss these results and related matters today at 1:30 p.m. PT (4:30 p.m. ET). Participating on the call will be Dave Mowry, Chief Executive Officer and Rohan Seth, Chief Financial Officer.

    To participate in the conference call, dial 1-877-705-6003 (domestic) or + 1-201-493-6725 (international) and refer to the Conference Code: 13719080.

    The call will also be webcast and can be accessed from the Investor Relations section of Cutera’s website at http://www.cutera.com/. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

    About Cutera, Inc.

    Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has developed innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.

    *Use of Non-GAAP Financial Measures

    In this press release, in order to supplement the Companys condensed consolidated financial statements presented in accordance with Generally Accepted Accounting Principles, or GAAP, management has disclosed certain non-GAAP financial measures for the statement of operations and net income (loss) per diluted share. Non-GAAP adjustments include stock-based compensation, depreciation, amortization, executive and other non-recurring separation costs, customer relationship management (CRM) and enterprise resource planning (ERP) system costs, non-recurring legal and litigation costs, as well as the net tax impact of excluding these items. From time to time in the future, there may be other items that we may exclude if the Company believes that doing so is consistent with the goal of providing useful information to investors and management. The Company has provided a reconciliation of each non-GAAP financial measure used in this earnings release to the most directly comparable GAAP financial measure. The Company has not provided a reconciliation of non-GAAP guidance measures to the corresponding GAAP measures on a forward-looking basis due to the potential significant variability, limited visibility, unpredictability, or unique non-recurring nature of the items. Forward-looking non-GAAP measures include adjusted EBITDA. The Company defines adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, stock-based compensation, executive and other non-recurring separation costs, customer relationship management and enterprise resource planning system costs, and non-recurring legal and litigation costs.

    Company management uses these measurements as aids in monitoring the Companys ongoing financial performance from quarter to quarter, and year to year, on a regular basis and for benchmarking against other similar companies. Non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. These non-GAAP financial measures should be considered along with, but not as alternatives to, the operating performance measure as prescribed by GAAP. Non-GAAP financial measures for the statement of operations and net income per diluted share exclude the following:

    Non-cash expenses for stock-based compensation. The Company has excluded the effect of stock-based compensation expenses in calculating its non-GAAP operating expenses and net income measures. Although stock-based compensation is a key incentive offered to the Company's employees, the Company continues to evaluate its business performance excluding stock-based compensation expenses. The Company records stock-based compensation expense related to grants of options, employee stock purchase plan, and performance and restricted stock. Depending upon the size, timing and the terms of the grants, this expense may vary significantly but will recur in future periods. The Company believes that excluding stock-based compensation better allows for comparisons to its peer companies;

    Depreciation and amortization. The Company has excluded depreciation and amortization expense in calculating its non-GAAP operating expenses and net income measures. Depreciation and amortization are non-cash charges to current operations;

    Executive and other non-recurring separation costs. We have excluded costs associated with the resignation of our former Executive Officers in calculating our non-GAAP operating expenses and net income measures. We exclude these and other non-recurring employee separation costs because we believe that these items do not reflect future operating expenses;

    Customer Relationship Management. We have excluded CRM system costs related to direct and incremental costs incurred in connection with our multi-phase implementation of a new CRM solution and the related technology infrastructure costs. We exclude these costs because we believe that these items do not reflect future operating expenses and will be inconsistent in amounts and frequency making it difficult to contribute to a meaningful evaluation of our operating performance;

    Enterprise Resource Planning. We have excluded ERP system costs related to direct and incremental costs incurred in connection with our multi-phase implementation of a new ERP solution and the related technology infrastructure costs. We exclude these costs because we believe that these items do not reflect future operating expenses and will be inconsistent in amounts and frequency making it difficult to contribute to a meaningful evaluation of our operating performance; and

    Non-recurring legal and litigation costs. We have excluded costs incurred related to third party litigation and disputes, that are of a non-recurring nature.

    The Company believes that excluding all of the items above allows users of its financial statements to better review and assess both current and historical results of operations.

    Safe Harbor Statement

    Certain statements in this press release, other than purely historical information, areforward-looking statementswithin the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (theExchange Act). These statements include, but are not limited to, Cuteras plans, objectives, strategies, financial performance and outlook, CFO and other senior leadership searches, product launches and performance, trends, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, the Companys actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such asmay,” “could,” “seek,” “guidance,” “predict,” “potential,” “likely,” “believe,” “will,” “should,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “forecast,” “foreseeor variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors, many of which are beyond the Companys control, that could cause its actual results to differ materially from the forward-looking statements contained in this press release, including those described in theRisk Factorssection of Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, the Registration Statement on Form S-,8 and other documents filed from time to time with the United States Securities and Exchange Commission by Cutera.

    All information in this press release is as of the date of its release. Accordingly, undue reliance should not be placed on forward-looking statements. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events. If the Company updates one or more forward-looking statements, no inference should be drawn that it will make additional updates with respect to those or other forward-looking statements. Cutera's financial performance for the first quarter ended March 31, 2021, as discussed in this release, is preliminary and unaudited, and subject to adjustment.

    CUTERA, INC. 
    CONDENSED CONSOLIDATED BALANCE SHEETS
    (in thousands) 
    (unaudited) 
               
               
        March 31     December 31,
    Reporting Unit Balance Sheet    

    2021

       

    2020

    Assets            
    Current assets:            
    Cash and cash equivalents   $

                       164,932

       $ 

                      47,047

    Accounts receivable, net    

                         24,151

       

                      21,962

    Inventories    

                         34,578

       

                      28,508

    Other current assets and prepaid expenses    

                         10,339

       

                        8,779

    Total current assets    

                       234,000

       

                    106,296

                 
    Property and equipment, net    

                           2,373

       

                        2,299

    Deferred tax asset    

                              598

       

                           643

    Goodwill    

                           1,339

       

                        1,339

    Operating lease right-of-use assets    

                         16,570

       

                      17,076

    Other long-term assets    

                           4,853

       

                        5,080

    Total assets   $

                       259,733

       $ 

                    132,733

               
    Liabilities and Stockholders' Equity            
    Current liabilities:            
    Accounts payable   $

                           5,031

       $ 

                        6,684

    Accrued liabilities    

                         41,329

       

                      31,079

    Operating leases liabilities    

                           2,351

       

                        2,260

    PPP Loan Payable    

                           6,352

       

                        3,630

    Extended warranty liabilities    

                           1,039

       

                        1,216

    Deferred revenue    

                         10,019

       

                        9,489

    Total current liabilities    

                         66,121

       

                      54,358

               
    Deferred revenue, net of current portion    

                           1,718

       

                        1,748

    PPP Loan payable, net of current portion    

                              851

       

                        3,555

    Operating lease liabilities, net of current portion    

                         15,394

       

                      15,950

    Convertible note, net of unamortized debt issuance costs of $4,665    

                       133,585

       

     - 

    Other long-term liabilities    

                              434

       

                           242

    Total liabilities    

                       218,103

       

                      75,853

               
    Stockholders’ equity:            
    Common stock    

                                18

       

                             18

    Additional paid-in capital    

                       102,206

       

                    117,097

    Accumulated deficit    

                        (60,594)

       

                    (60,235)

    Total stockholders' equity    

                         41,630

       

                      56,880

    Total liabilities and stockholders' equity   $

                       259,733

       $ 

                    132,733

               
       

                           -

       

                        -

    CUTERA, INC. 
    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
    (in thousands, except per share data)
    (unaudited) 
                    
             
      Three Months Ended
               
      March 31,   March 31,
     

    2021

     

    2020

             
    Products   $

               43,551

      $

    26,391

    Service    

                 6,117

       

    5,848

    Total net revenue    

               49,668

       

    32,239

               
    Products    

               18,331

       

    14,103

    Service    

                 3,627

       

    3,800

    Total cost of revenue    

               21,958

       

    17,903

    Gross profit    

               27,710

        

    14,336

    Gross margin %    

    56%

       

    44%

             
    Operating expenses:           
    Sales and marketing    

               15,068

       

    14,789

    Research and development    

                 4,112

       

    3,870

    General and administrative    

                 7,365

       

    7,806

    Total operating expenses    

               26,545

        

    26,465

    Income (loss) from operations    

                 1,165

        

    (12,129)

    Interest and other expense, net          
    Amortization of debt issuance costs    

                    (52)

       

    -

    Interest on convertible notes    

                  (191)

       

    -

    Other expense, net    

               (1,023)

       

    (207)

    Total Interest and other expense, net    

               (1,266)

       

    (207)

    Loss before income taxes    

                  (101)

        

    (12,336)

    Income tax expense    

                    258

       

    78

    Net loss   $

                  (359)

       $

    (12,414)

             
    Net loss per share:          
    Basic   $

                 (0.02)

       $ 

    (0.86)

    Diluted   $

                 (0.02)

       $ 

    (0.86)

             
    Weighted-average number of shares used in per share calculations:          
    Basic    

               17,768

       

    14,433

    Diluted    

               17,768

       

    14,433

    CUTERA, INC. 
    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
    (in thousands) 
    (unaudited) 
       
         Three Months Ended
        March 31,   March 31,
     

    2021

     

    2020

    Cash flows from operating activities:            
    Net loss   $

                          (359)

      $

             (12,414)

    Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
    Stock-based compensation    

                         1,846

       

                 1,980

    Depreciation of tangible assets    

                            361

       

                    360

    Amortization of contract acquisition costs    

                            545

       

                    717

    Amortization of  debt issuance costs    

                              52

       

     - 

    Impairment of capitalized cloud computing costs    

                            182

       

                         -

    Change in deferred tax asset    

                              45

       

                      15

    Provision for credit losses    

                            218

       

                    590

    Gain on sale of property and equipment    

                            (59)

       

     - 

    Change in right-of-use asset    

                            604

       

                    645

    Other    

     - 

       

                      35

    Changes in assets and liabilities:            
    Accounts receivable    

                       (2,407)

       

                 5,306

    Inventories    

                       (6,021)

       

               (3,020)

    Other current assets and prepaid expenses    

                       (1,560)

       

                    807

    Other long-term assets    

                          (500)

       

                  (207)

    Accounts payable    

                       (1,653)

       

                 1,919

    Accrued liabilities    

                       10,199

       

               (6,567)

    Extended warranty liabilities    

                          (177)

       

                  (234)

    Operating lease liabilities    

                          (563)

       

                  (645)

    Deferred revenue    

                            500

       

               (1,253)

    Net cash provided by (used in) operating activities    

                         1,253

       

             (11,966)

               
    Cash flows from investing activities:            
    Acquisition of property, equipment and software    

                          (101)

       

                  (230)

    Proceeds from disposal of property and equipment    

                              52

       

                         -

    Proceeds from sales of marketable investments    

     - 

       

                 6,800

    Purchase of marketable investments    

     - 

       

               (3,930)

    Net cash provided by (used in) investing activities    

                            (49)

       

                 2,640

                   
    Cash flows from financing activities:            
    Proceeds from exercise of stock options and employee stock purchase plan  

                            396

       

                    201

    Purchase of capped call    

                     (16,134)

       

                         -

    Proceeds from issuance of convertible notes    

                     138,250

       

     - 

    Payment of issuance costs of convertible notes    

                       (4,717)

       

     - 

    Taxes paid related to net share settlement of equity awards    

                          (999)

       

               (2,234)

    Payments on finance lease obligations    

                          (115)

       

                  (183)

    Net cash provided by (used in) financing activities    

                     116,681

       

               (2,216)

               
    Net increase (decrease) in cash and cash equivalents    

                     117,885

       

             (11,542)

    Cash and cash equivalents at beginning of period    

                       47,047

       

               26,316

    Cash and cash equivalents at end of period   $

                     164,932

       $ 

               14,774

    CUTERA, INC. 
    CONSOLIDATED FINANCIAL HIGHLIGHTS
    (in thousands, except percentage data)
    (unaudited) 
      
      Three Months Ended    % Change
      March 31,    March 31,    2021 Vs
     

    2021

     

    2020

     

    2020

    Revenue By Geography:                
    North America   $

                        22,396

      $

                      15,373

      +46%
    Japan    

                        16,555

       

                        7,162

      +131%
    Rest of World    

                        10,717

       

                        9,704

      +10%
    Total Net Revenue   $

                        49,668

      $

                      32,239

      +54%
    Rest of World (including Japan) as a percentage of total revenue    

    55%

       

    52%

       
                       
    Revenue By Product Category:                
    Systems                
    - North America   $

                        16,785

      $

                      10,382

      +62%
    - Rest of World (including Japan)    

                        11,536

       

                      10,576

      +9%
    Total Systems    

                        28,321

       

                      20,958

      +35%
    Consumables    

                          2,925

       

                        2,533

      +15%
    Skincare    

                        12,306

       

                        2,900

      +324%
    Total Products    

                        43,552

       

                      26,391

      +65%
                   
    Service    

                          6,116

       

                        5,848

      +5%
    Total Net Revenue   $

                        49,668

      $

                      32,239

      +54%
                   
                   
                     
      Three Months Ended     
        March 31,    March 31,     
       

    2021

     

    2020

       
    Pre-tax Stock-Based Compensation Expense:                
    Cost of revenue   $

                             144

      $

                           290

       
    Sales and marketing    

                             721

       

                           719

       
    Research and development    

                             301

       

                           321

       
    General and administrative

                             680

                           650

      $

                          1,846

      $

                        1,980

       

    CUTERA, INC. 

    RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    TO  NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (in thousands, except per share data)

    (unaudited) 

                                         
             
    Three Months Ended March 31, 2021   Three Months Ended March 31, 2020
    GAAP   Depreciation
    and
    Amortization
      Stock-Based
    Compensation
      CRM and ERP
    Implementation
    /write-off
      Legal - Lutronic   Taxes and
    Other
    Adjustments
        Non-GAAP   GAAP Depreciation
    and
    Amortization
      Stock-Based
    Compensation
      CRM and ERP
    Implementation/
    write-off
      Taxes and
    Other
    Adjustments
    Non-GAAP
                   
    Net revenue

     $

         49,668

     

     

                            -

     

     

     

                                    -

     

     

     

                                 -

     

     

     

                                         -

     

     

     

                            -

     $

                  49,668

     

     

     $

              32,239

     

                            -

     

     

                               -

     

     

                                             -

     

     

                           -

     

     $

          32,239

     

    Cost of revenue

     

            21,958

     

     

                     (162

    )

     

     

                              (144

    )

     

     

                                 -

     

     

     

                                         -

     

     

     

                            -

     

                     21,652

     

     

     

                 17,903

     

                     (140

    )

     

                         (290

    )

     

                                             -

     

     

                           -

     

     

             17,473

     

    Gross profit

     

            27,710

     

     

                       162

     

     

     

                               144

     

     

     

                                 -

     

     

     

                                         -

     

     

     

                            -

     

                     28,016

     

     

     

                 14,336

     

                       140

     

     

                           290

     

     

                                             -

     

     

                           -

     

     

             14,766

     

    Gross margin %

     

    56%

           

     

    56%

     

     

    44%

         

     

    46%

                   
    Operating expenses:                
    Sales and marketing

     

            15,068

     

     

                     (678

    )

     

     

                              (721

    )

     

     

                          (182

    )

     

     

                                         -

     

     

     

                            -

     

                     13,487

     

     

     

                 14,789

     

                     (871

    )

     

                         (718

    )

     

                                       (165

    )

     

                           -

     

     

             13,035

     

    Research and development

     

              4,112

     

     

                       (39

    )

     

     

                              (301

    )

     

     

                                 -

     

     

     

                                         -

     

     

     

                            -

     

                       3,772

     

     

     

                   3,870

     

                       (38

    )

     

                         (321

    )

     

                                             -

     

     

                           -

     

     

               3,511

     

    General and administrative

     

              7,365

     

     

                       (27

    )

     

     

                              (680

    )

     

     

                            (70

    )

     

     

                                   (401

    )

     

     

                            -

     

                       6,187

     

     

     

                   7,806

     

                       (28

    )

     

                         (651

    )

     

                                       (244

    )

     

                     (324

    )

     

               6,559

     

    Total operating expenses

     

            26,545

     

     

                     (744

    )

     

     

                           (1,702

    )

     

     

                          (252

    )

     

     

                                   (401

    )

     

     

                            -

     

                     23,446

     

     

     

                 26,465

     

                     (937

    )

     

                      (1,690

    )

     

                                       (409

    )

     

                     (324

    )

     

             23,105

     

    Income (loss) from operations

     

              1,165

     

     

                       906

     

     

     

                            1,846

     

     

     

                            252

     

     

     

                                     401

     

     

     

                            -

     

                       4,570

     

     

     

               (12,129

    )

                    1,077

     

     

                        1,980

     

     

                                        409

     

     

                      324

     

     

             (8,339

    )

    Interest and other expense, net                
    Amortization of debt issuance costs

     

                 (52

    )

     

                            -

     

     

     

                                    -

     

     

     

                                 -

     

     

     

                                         -

     

     

     

                            -

     

                          (52

    )

     

     

                          -

     

                            -

     

     

                               -

     

     

                                             -

     

     

                           -

     

     

                      -

     

    Interest on convertible notes

     

               (191

    )

     

                            -

     

     

     

                                    -

     

     

     

                                 -

     

     

     

                                         -

     

     

     

                            -

     

                        (191

    )

     

     

                          -

     

                            -

     

     

                               -

     

     

                                             -

     

     

                           -

     

     

                      -

     

    Other expense, net

     

            (1,023

    )

     

                           -

     

     

     

                                   -

     

     

     

                                -

     

     

     

                                         -

     

     

     

                           -

     

                     (1,023

    )

     

     

                    (207

    )

                           -

     

     

                               -

     

     

                                            -

     

     

                          -

     

     

                (207

    )

    Total interest and other expense, net

     

            (1,266

    )

     

                            -

     

     

     

                                    -

     

     

     

                                 -

     

     

     

                                         -

     

     

     

                            -

     

                     (1,266

    )

     

     

                    (207

    )

                            -

     

     

                               -

     

     

                                             -

     

     

                           -

     

     

                (207

    )

    Income (loss) before income taxes

     

               (101

    )

     

                       906

     

     

     

                            1,846

     

     

     

                            252

     

     

     

                                     401

     

     

     

                            -

     

                       3,304

     

     

     

               (12,336

    )

                    1,077

     

     

                        1,980

     

     

                                        409

     

     

                      324

     

     

             (8,546

    )

    Provision for income taxes

     

                 258

     

     

                           -

     

     

     

                                   -

     

     

     

                                -

     

     

     

                                         -

     

     

     

                           -

     

                          258

     

     

     

                        78

     

                           -

     

     

                               -

     

     

                                            -

     

     

                          5

     

     

                    83

     

    Net income (loss)

     $

            (359

    )

     $

                    906

     

     

     $

                         1,846

     

     

     $

                         252

     

     

     $

                                  401

     

     

     $

                         -

     $

                    3,046

     

     

     $

            (12,414

    )

                    1,077

     

     

                        1,980

     

     

                                        409

     

     

                      319

     

     $

          (8,629

    )

                   
    Net income (loss) per share:                
    Basic

     $

           (0.02

    )

           

     $

                      0.17

     

     

     $

                (0.86

    )

         

     $

            (0.60

    )

    Diluted

     $

           (0.02

    )

           

     $

                      0.15

     

     

     $

                (0.86

    )

         

     $

            (0.60

    )

                   
    Weighted-average number of shares used in per share calculations:                
    Basic

     

            17,768

     

           

     

                     17,768

     

     

     

                 14,433

     

         

     

             14,433

     

    Diluted

     

            17,768

     

           

     

                     22,266

     

     

     

                 14,433

     

         

     

             14,433

     

                   
                   
                                                         
                                         
    Operating expenses as a % of net revenue   GAAP                         Non-GAAP   GAAP       Non-GAAP
    Sales and marketing  

    30.3%

                           

    27.2%

     

    45.9%

         

    40.4%

    Research and development  

    8.3%

                           

    7.6%

     

    12.0%

         

    10.9%

    General and administrative  

    14.8%

                           

    12.5%

     

    24.2%

         

    20.3%

     

    53.4%

                           

    47.2%

     

    82.1%

         

    71.7%

    CUTERA, INC. 
    RECONCILIATION OF LOSS TO ADJUSTED EBITDA
    (in thousands)
    (unaudited) 
       
       
      Three Months
    Ended
     

    March 31, 2021

       
    Net loss  

     $

                  (359

    )

    Adjustments:    
    Stock-based compensation  

     

                    1,846

     

    Depreciation and amortization  

     

                       906

     

    CRM and ERP implementation/ write off  

     

                       252

     

    Legal - Lutronic  

     

                       401

     

    Interest and other expense, net  

     

                    1,266

     

    Provision for income taxes  

     

                       258

     

    Total adjustments  

     $

                 4,929

     

       
    Adjusted EBITDA  

     $

                 4,570

     

     




    Business Wire (engl.)
    0 Follower
    Autor folgen

    Cutera, Inc. Announces First Quarter 2021 Financial Results Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the first quarter ended March 31, 2021. First Quarter …